bluebird bio (BLUE) Prices 9.09M Share Common Offering at $55/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Pre-Open Movers 05/18: (SRNE) (MRNA) (FLGT) Higher; (CTRC) (FSCT) (GSX) Lower (more...)
May 18, 2020 9:26 AM EDTToday's Pre-Open Stock Movers
Centric Brands Inc. (NASDAQ: CTRC) 52.8% LOWER; announced today that it has entered into a Restructuring Support Agreement (RSA or the agreement) with substantially all of the Companys secured lenders, led by certain funds managed by Blackstone (Blackstone), Ares Management Corporation (Ares), and HPS Investment Partners (HPS), to recapitalize the Company, provide $435 million in debtor-in-possession financing and allow the Company to operate without interruption throughout the restructuring process.
Sorrento Therapeutics (NASDAQ: SRNE) 35.5% HIGHER; Adds to Friday's Gain, Up 35%... More
bluebird bio (BLUE) Announces Proposed $400 Million Public Offering of Common Stock
May 18, 2020 7:00 AM EDTbluebird bio, Inc. (Nasdaq: BLUE) today announced that it has commenced an underwritten public offering of $400 million of its common stock. bluebird bio also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the... More
